Welcome to LookChem.com Sign In|Join Free

CAS

  • or

87100-28-5

Post Buying Request

87100-28-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

87100-28-5 Usage

Uses

Benzylboronic acid pinacol ester finds application in Pd (0)-mediated [11 C] carbonylation reaction.

Check Digit Verification of cas no

The CAS Registry Mumber 87100-28-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,7,1,0 and 0 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 87100-28:
(7*8)+(6*7)+(5*1)+(4*0)+(3*0)+(2*2)+(1*8)=115
115 % 10 = 5
So 87100-28-5 is a valid CAS Registry Number.
InChI:InChI=1/C13H19BO2/c1-12(2)13(3,4)16-14(15-12)10-11-8-6-5-7-9-11/h5-9H,10H2,1-4H3

87100-28-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (B3448)  2-Benzyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane  >97.0%(GC)

  • 87100-28-5

  • 1g

  • 350.00CNY

  • Detail
  • TCI America

  • (B3448)  2-Benzyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane  >97.0%(GC)

  • 87100-28-5

  • 5g

  • 1,300.00CNY

  • Detail
  • Alfa Aesar

  • (H32523)  Benzylboronic acid pinacol ester, 96%   

  • 87100-28-5

  • 1g

  • 625.0CNY

  • Detail
  • Alfa Aesar

  • (H32523)  Benzylboronic acid pinacol ester, 96%   

  • 87100-28-5

  • 5g

  • 2007.0CNY

  • Detail
  • Alfa Aesar

  • (H32523)  Benzylboronic acid pinacol ester, 96%   

  • 87100-28-5

  • 25g

  • 7632.0CNY

  • Detail

87100-28-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name Benzylboronic acid pinacol ester

1.2 Other means of identification

Product number -
Other names 4,4,5,5-tetramethyl-2-(phenylmethyl)-1,3,2-dioxaborolane

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:87100-28-5 SDS

87100-28-5Relevant articles and documents

Selective Benzylic CH-Borylations by Tandem Cobalt Catalysis

Bauer, Matthias,Ghosh, Pradip,Jacobi von Wangelin, Axel,Schoch, Roland

, (2021/11/27)

Metal-catalyzed C?H activations are environmentally and economically attractive synthetic strategies for the construction of functional molecules as they obviate the need for pre-functionalized substrates and minimize waste generation. Great challenges reside in the control of selectivities, the utilization of unbiased hydrocarbons, and the operation of atom-economical dehydrocoupling mechanisms. An especially mild borylation of benzylic CH bonds was developed with the ligand-free pre-catalyst Co[N(SiMe3)2]2 and the bench-stable and inexpensive borylation reagent B2pin2 that produces H2 as the only by-product. A full set of kinetic, spectroscopic, and preparative mechanistic studies are indicative of a tandem catalysis mechanism of CH-borylation and dehydrocoupling via molecular CoI catalysts.

The functionalization of benzene by boranes using trispyrazolylborate complexes

Vetter, Andrew J.,DiBenedetto, Tarah A.,Ritz, Mikhaila D.,Jones, William D.

, (2021/02/03)

The catalytic C[sbnd]H activation and borylation of arenes by trispyrazolylborate complexes is reported. Trispyrazolylborate rhodium and iridium complexes have been previously shown to activate a variety of C[sbnd]H bonds. Here, we show the catalytic borylation of arenes by the trispyrazolylborate ethylene complexes Tp'Rh(C2H4)2, and Tp'Ir(C2H4)2.

Boronic acid derivatives

-

Paragraph 0113; 0124-0127; 0302; 0305-0308, (2021/07/21)

The present invention relates to boronic acid derivatives; the present invention provides compounds of formula (I) or pharmaceutically acceptable salts, solvates, polymorphs or isomers thereof, pharmaceutical compositions comprising these compounds, and uses of such compounds in the treatment of lmp7-related diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 87100-28-5